Wockhardt US unit gets FDA warning notePost published:March 1, 2017Post category:Industry NewsProducts of Wockhardt’s US unit Morton Grove Pharma will be available in that market but new approvals will be withheld until compliance issues are resolved Source: Livemint.com (http://www.livemint.com/rss/industry)Read more articlesPrevious PostMasterCard eyes 1 million traders on its BharatQR platformNext PostYahoo chief counsel exits after hack probe finds inaction You Might Also Like Eaton announces release of electrohydraulic cylinders with valve integration March 15, 2018 ABB helps enhance Spanish indoor skydiving facility with variable speed drives January 31, 2019 Balluff releases BIS VU-320 UHF reader March 30, 2018